Literature DB >> 25552357

Control of the T follicular helper-germinal center B-cell axis by CD8⁺ regulatory T cells limits atherosclerosis and tertiary lymphoid organ development.

Marc Clement1, Kevin Guedj1, Francesco Andreata1, Marion Morvan1, Laetitia Bey1, Jamila Khallou-Laschet1, Anh-Thu Gaston1, Sandrine Delbosc1, Jean-Marc Alsac1, Patrick Bruneval1, Catherine Deschildre1, Marie Le Borgne1, Yves Castier1, Hye-Jung Kim1, Harvey Cantor1, Jean-Baptiste Michel1, Giuseppina Caligiuri1, Antonino Nicoletti2.   

Abstract

BACKGROUND: The atheromodulating activity of B cells during the development of atherosclerosis is well documented, but the mechanisms by which these cells are regulated have not been investigated. METHODS AND
RESULTS: Here, we analyzed the contribution of Qa-1-restricted CD8(+) regulatory T cells to the control of the T follicular helper-germinal center B-cell axis during atherogenesis. Genetic disruption of CD8(+) regulatory T cell function in atherosclerosis-prone apolipoprotein E knockout mice resulted in overactivation of this axis in secondary lymphoid organs, led to the increased development of tertiary lymphoid organs in the aorta, and enhanced disease development. In contrast, restoring control of the T follicular helper-germinal center B-cell axis by blocking the ICOS-ICOSL pathway reduced the development of atherosclerosis and the formation of tertiary lymphoid organs. Moreover, analyses of human atherosclerotic aneurysmal arteries by flow cytometry, gene expression analysis, and immunofluorescence confirmed the presence of T follicular helper cells within tertiary lymphoid organs.
CONCLUSIONS: This study is the first to demonstrate that the T follicular helper-germinal center B-cell axis is proatherogenic and that CD8(+) regulatory T cells control the germinal center reaction in both secondary and tertiary lymphoid organs. Therefore, disrupting this axis represents an innovative therapeutic approach.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  atherosclerosis; inflammation; leukocytes

Mesh:

Substances:

Year:  2014        PMID: 25552357     DOI: 10.1161/CIRCULATIONAHA.114.010988

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  54 in total

Review 1.  T Follicular Helper Cell Biology: A Decade of Discovery and Diseases.

Authors:  Shane Crotty
Journal:  Immunity       Date:  2019-05-21       Impact factor: 31.745

Review 2.  Beyond vascular inflammation--recent advances in understanding atherosclerosis.

Authors:  Dennis Wolf; Andreas Zirlik; Klaus Ley
Journal:  Cell Mol Life Sci       Date:  2015-06-23       Impact factor: 9.261

Review 3.  Atherosclerosis in the single-cell era.

Authors:  Holger Winkels; Erik Ehinger; Yanal Ghosheh; Dennis Wolf; Klaus Ley
Journal:  Curr Opin Lipidol       Date:  2018-10       Impact factor: 4.776

Review 4.  The immunology of atherosclerosis.

Authors:  Anton Gisterå; Göran K Hansson
Journal:  Nat Rev Nephrol       Date:  2017-04-10       Impact factor: 28.314

5.  Rituximab Monotherapy for Common Variable Immune Deficiency-Associated Granulomatous-Lymphocytic Interstitial Lung Disease.

Authors:  Julie Ng; Kyle Wright; Maura Alvarez; Gary M Hunninghake; Duane R Wesemann
Journal:  Chest       Date:  2019-05       Impact factor: 9.410

6.  Regulatory B cells, interleukin-10, and atherosclerosis.

Authors:  Hong Lu; Alan Daugherty
Journal:  Curr Opin Lipidol       Date:  2015-10       Impact factor: 4.776

7.  The molecular systemic and local effects of intra-tendinous injection of Platelet Rich Plasma in tendinosis: preliminary results on a rat model with ELISA method.

Authors:  Benjamin Dallaudiere; Liliane Louedec; Marie Paule Jacob Lenet; Lionel Pesquer; Elvind Blaise; Anne Perozziello; Jean Baptiste Michel; Maryse Moinard; Philippe Meyer; Jean Michel Serfaty
Journal:  Muscles Ligaments Tendons J       Date:  2015-07-03

8.  STAT4 Regulates the CD8+ Regulatory T Cell/T Follicular Helper Cell Axis and Promotes Atherogenesis in Insulin-Resistant Ldlr-/- Mice.

Authors:  Parésa L Taghavie-Moghadam; Tayab C Waseem; Julian Hattler; Lindsey M Glenn; Anca D Dobrian; Mark H Kaplan; Yi Yang; Roza Nurieva; Jerry L Nadler; Elena V Galkina
Journal:  J Immunol       Date:  2017-10-20       Impact factor: 5.422

Review 9.  Once Upon a Time: The Adaptive Immune Response in Atherosclerosis--a Fairy Tale No More.

Authors:  Marie Le Borgne; Giuseppina Caligiuri; Antonino Nicoletti
Journal:  Mol Med       Date:  2015-10-27       Impact factor: 6.354

Review 10.  Immune checkpoint proteins: exploring their therapeutic potential to regulate atherosclerosis.

Authors:  A C Foks; J Kuiper
Journal:  Br J Pharmacol       Date:  2017-05-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.